Australia markets close in 1 hour 29 minutes

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.96+0.12 (+1.75%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close6.84
Open6.86
Bid7.00 x 1200
Ask9.45 x 1000
Day's range6.86 - 7.35
52-week range6.80 - 36.72
Volume39,107
Avg. volume18,048
Market cap58.167M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-3.27
Earnings date07 Mar 2022 - 11 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est27.17
  • Zacks

    Down 16.1% in 4 Weeks, Here's Why Lumos (LUMO) Looks Ripe for a Turnaround

    Lumos (LUMO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

  • Simply Wall St.

    We're Hopeful That Lumos Pharma (NASDAQ:LUMO) Will Use Its Cash Wisely

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

  • GlobeNewswire

    Lumos Pharma to Participate in Upcoming Investor Conferences

    AUSTIN, Texas, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company will participate in the following upcoming investor conferences: Event: Stifel 2021 Virtual Healthcare Conference – November 16th - 17th Presentation: Presentation November 16th from 3:20-3:50 PM EST 1x1 Meetings: Virtual one-on-one meetings with management November 16th throughout the day Webcast link: